WallStreetZenWallStreetZen

How to Buy Gilead Sciences Stock

Gilead Sciences Inc

Gilead Sciences, Inc. , a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Gilead Sciences stock last closed at $66.17, down 2.4% from the previous day, and has decreased 15.79% in one year. It has underperformed other stocks in the Drug Manufacturers - General industry by 0.35 percentage points. Gilead Sciences stock is currently +2.86% from its 52-week low of $64.33, and -24.69% from its 52-week high of $87.87.

There are currently 1.25B GILD shares outstanding. The market value of GILD is $82.44B. In the last 24 hours, 5.6M GILD shares were traded.

How to Buy Gilead Sciences Stock

Not sure how to invest in Gilead Sciences stock? Here's how.
  1. Decide where to buy Gilead Sciences stock: You need to pick an online brokerage, but don't worry - we've researched dozens of online brokerages and apps to help you decide where to buy Gilead Sciences stock.
  2. Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
  3. Deposit funds into your brokerage account: Choose your method of payment and add your details.
  4. Analyze Gilead Sciences stock: The Gilead Sciences ticker symbol is GILD. Is Gilead Sciences stock a good investment? Should you buy shares of GILD? How do GILD's underlying business fundamentals look? Do top analysts think Gilead Sciences is a good buy? Why has GILD's stock price moved recently? (Hint: Our stock analysis website can help you figure out if GILD is a good stock to buy).
  5. Execute your GILD purchase: Decide if you will purchase GILD shares at the current market price or use a limit order to buy GILD shares at a specific price.
  6. Keep tabs on your investment in GILD: Create a watchlist to track your position in Gilead Sciences shares.

Step 1: Decide where to buy Gilead Sciences stock

You will need an online brokerage account to access the NASDAQ market and buy GILD stock.

A brokerage account is an investment account that enables you to buy and sell a variety of financial instruments, including stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

Based on our research, eToro is the best brokerage. eToro gives you:

  • Invest in stocks with 0% commissions: Invest without commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
  • Access to world markets: From Technology to Real Estate, New York to Shanghai — you can fill your portfolio with stocks from the globe's top exchanges.
  • Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other assets: Such as ETFs and cryptos.

Get $10 towards your stock purchase by creating an account with eToro now.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Sign up for your brokerage account

Now that you've picked the right brokerage, you need to fill out some personal details so you can invest in GILD today.

How to Set Up a New Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Input your personal details to open a new brokerage account.
  1. Submit your details by hitting the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit funds into your brokerage account

Now that you've filled out your info on one of the most highly reviewed stock market apps, you can securely and quickly fund your account:

Watch the tutorial below to see the process of transferring funds into your new investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Analyze Gilead Sciences stock

After you have decided on the best place to buy Gilead Sciences stock, it's crucial to research their stock prior to buying, so you truly wrap your head around the risk and opportunity.

Gilead Sciences stock data

GILD Price
$66.17
1w %
-2.49%
1y %
-15.79%
5y %
-1.49%
P/E
165.43x
P/B
4.7x
P/S
3.01x
PEG
1.03x
Revenue
$27.45B
Earnings
$484.00M
Fore. Rev. Growth
1.5%
Fore. Earn. Growth
159.87%
Market Cap
$82.44B
Next Earnings
Jun 12, 2024
Next Dividend
Jun 27, 2024

Gilead Sciences Overview

WallStreetZen was designed to help everyday investors do more accurate fundamental analysis in less time.

You can see all of the due diligence checks on GILD's stock page.

Is GILD stock undervalued?

You can use many financial metrics, analyses, models, and charts to gauge GILD's intrinsic value.

Using relative valuations measures:

  • GILD may be overvalued based on its P/E ratio of 165.43x, relative to Drug Manufacturers - General industry P/E ratio of 33.81x
  • GILD may be undervalued based on its P/B ratio of 4.7x, relative to Drug Manufacturers - General industry P/B ratio of 6.42x
  • GILD could be overvalued based on its PEG ratio of 1.03x

You can access additional valuation analysis on GILD's stock here.

How do GILD Financials look?

Positive Health Checks:

  • There are more short-term assets than short-term liabilities on the GILD balance sheet.
  • GILD's operating cash flow of $8.48B allows it to safely service it's debt of $25.19B.

Negative Health Checks:

  • Total GILD debt is higher than 5 years ago, relative to shareholder equity.
  • GILD has a relatively high debt to equity ratio of 2.21.
  • There are more long-term liabilities than short-term assets on the GILD balance sheet.
  • GILD earnings of $2.07B is not enough to cover its interest payments.
  • GILD profit margin has gone down from 20.6% to 1.8% in the past year.

Is it a good time to buy Gilead Sciences stock, according to analysts?

Out of 11 Wall Street analysts who monitor GILD, the consensus analyst rating on Gilead Sciences is a Buy

It's important to keep in mind that analyst ratings are not recommendations, nor are they investment advice.

Latest GILD Analyst Forecasts

Hartaj Singh, a top 24% analyst from Oppenheimer maintains GILD with a buy rating and maintains their GILD price target from $105.00 to $105.00, on Apr 19, 2024.

Colin Bristow, a bottom 15% analyst from UBS maintains GILD with a hold rating and lowers their GILD price target from $81.00 to $75.00, on Apr 17, 2024.

Mohit Bansal, a top 9% analyst from Wells Fargo maintains GILD with a hold rating and lowers their GILD price target from $84.00 to $78.00, on Mar 4, 2024.

Salim Syed, a bottom 14% analyst from Mizuho maintains GILD with a strong buy rating and lowers their GILD price target from $101.00 to $90.00, on Feb 22, 2024.

Robyn Karnauskas, a bottom 5% analyst from Truist Securities downgrades GILD to a hold rating and lowers their GILD price target from $91.00 to $82.00, on Feb 22, 2024.

You can dive deeper into what analysts are saying on the Gilead Sciences stock forecast page.

GILD Momentum

SMA10
67.29
SMA20
66.28
SMA50
68.63
SMA100
73.17
SMA200
75.28
MACD
-0.22
MACD Signal
-0.51
MACD Histogram
0.3
RSI
43.65
Stochastic %K
68.19
Stochastic %D
77.52
StochRSI %K
78.42
StochRSI %D
88.47

GILD Revenue

Last year, GILD earnings were $484.00M. In the past 5 year, GILD's earnings have increased by -38.59% per year. This was slower than the Drug Manufacturers - General industry average of 0.51%.

Last year, GILD revenue was $27.45B. In the past 5 year, GILD's revenue has gone up by 4.22% per year. This was slower than the Drug Manufacturers - General industry average of 7.36%.

Dive into GILD's earnings and revenue performance here.

What are GILD insiders up to?

In the last year, insiders at GILD have sold more shares than they have bought.

Harish Manwani, Director of GILD, was the latest GILD insider to sell. They sold $29,278.92 worth of GILD stock on May 8, 2024.

Get more info about who owns GILD stock here.

Can I get consistent income from GILD stock?

Gilead Sciences pays a dividend of 4.56%, compared to the Drug Manufacturers - General industry's average dividend yield of 3.62%. If you owned $1,000 worth of GILD stock, you would have been paid $45.64 last year.

Gilead Sciences dividend payments have consistently grown over the past 9 years and have remained stable.

Find more info about Gilead Sciences dividend yield and history here.

GILD Social Trading Data

One of the primary reasons eToro is our favorite brokerage is because of its social trading community.

Click below to find out what other community members have to say.

Step 5: Execute your GILD purchase

There are two primary options:

  • Market order: A market order is an order to buy or sell a security at the best possible price.
    Market orders are usually fine.
  • Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
    If you want to make sure you're buying or selling at a given price, place a limit order.

Press the Open Trade button and your broker will execute your order.

If you want additional assistance buying stocks on eToro, click the helpful video below:

Open eToro Account

Step 6: Keep tabs on your investment in GILD

Now that you own some GILD stock, you'll want to stay up-to-date on your new stock purchase.

Put GILD on a watchlist to track your GILD stock.

GILD Feed

How to Buy Stock in Gilead Sciences

To reiterate, here are the 6 steps to buy stock in Gilead Sciences:

  1. Decide where to buy Gilead Sciences stock
  2. Sign up for your brokerage account
  3. Deposit funds into your brokerage account
  4. Analyze Gilead Sciences stock
  5. Execute your GILD purchase
  6. Keep tabs on your investment in GILD

If you require a brokerage account, eToro is our recommended option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to get updates on your investment in Gilead Sciences, create your watchlist below.

NASDAQ: GILD
$66.17-1.63 (-2.4%)
Updated May 23, 2024
Open eToro Account
NASDAQ: GILD
$66.17-1.63 (-2.4%)
Updated May 23, 2024
Open eToro Account

FAQ

How much does it cost to buy one Gilead Sciences share?

As of May 23, 2024, it costs $66.17 to buy one share of Gilead Sciences stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.151 shares of GILD.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Gilead Sciences stock?

According to 11 Wall Street analysts who monitor Gilead Sciences, their consensus recommendation is to buy Gilead Sciences stock.

What is the best way to buy Gilead Sciences stock?

One way to place an order for Gilead Sciences stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.